<DOC>
	<DOCNO>NCT01966718</DOCNO>
	<brief_summary>It hypothesize repository corticotropin injection combination biologic agent able provide relief rheumatoid arthritis acute exacerbation rheumatoid arthritis patient disease inadequately responded biologics previously .</brief_summary>
	<brief_title>Repository Corticotropin Injection To Treat Rheumatoid Arthritis Patients Who Have Failed Three Biologic Therapies .</brief_title>
	<detailed_description>Although many type treatment rheumatoid arthritis ( RA ) currently available , patient disease refractory treatment achieve remission . The objective study ass efficacy safety subcutaneous injection repository corticotropin adjunct therapy patient active RA inadequate response least two biologic agent well third agent currently receive .</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<mesh_term>Adrenocorticotropic Hormone</mesh_term>
	<criteria>Rheumatoid arthritis least 2 year duration On least third biologic different mechanism action least 12 week Active disease define least 6 tender 6 swollen joint Erythrocyte sedimentation rate ( ESR ) least 28 mm/hr Creactive protein ( CRP ) least 1.2 time upper limit normal Stable dose disease modify antirheumatic drug ( DMARD ) prednisone least 4 week Prior treatment Acthar Gel History intolerance allergy glucocorticoid Unstable diabetes Active infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Rheumatoid arthritis</keyword>
	<keyword>Joint pain</keyword>
	<keyword>Repository corticotropin injection</keyword>
</DOC>